(Q51385423)

4 April 2018

title

Reproducibility study of [(18)F]FPP(RGD)2 uptake in murine models of human tumor xenografts. (English)

1 reference

4 April 2018

1 reference

1 reference

1 reference

1 reference

Edwin Chang

1

1 reference

4 April 2018

Shuangdong Liu

2

1 reference

4 April 2018

Gayatri Gowrishankar

3

1 reference

4 April 2018

Shahriar Yaghoubi

4

1 reference

4 April 2018

James Patrick Wedgeworth

5

1 reference

4 April 2018

Frederick Chin

6

1 reference

4 April 2018

Dietmar Berndorff

7

1 reference

4 April 2018

Volker Gekeler

8

1 reference

4 April 2018

Sanjiv S Gambhir

9

1 reference

4 April 2018

Zhen Cheng

10

1 reference

4 April 2018

publication date

2 December 2010

1 reference

4 April 2018

number of pages

9

1 reference

European Journal of Nuclear Medicine and Molecular Imaging

inferred from page(s)

published in

1 reference

4 April 2018

volume

38

1 reference

4 April 2018

issue

4

1 reference

4 April 2018

page(s)

722-730

1 reference

4 April 2018

https://scigraph.springernature.com/pub.10.1007/s00259-010-1672-1

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Alpha v integrins as receptors for tumor targeting by circulating ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

An integrin alpha(v)beta(3)-c-Src oncogenic unit promotes anchorage-independence and tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Integrins and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Anchorage dependence, integrins, and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

RGD and other recognition sequences for integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Phase I and correlative biology study of cilengitide in patients with recurrent malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Substituted benzocyloheptenes as potent and selective alpha(v) integrin antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

alphav beta 3 and alphav beta 5 integrin antagonists inhibit angiogenesis in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Imaging of integrin alphavbeta3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Stimulation of tumor growth and angiogenesis by low concentrations of RGD-mimetic integrin inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Ligands for mapping alphavbeta3-integrin expression in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Radiolabeled multimeric cyclic RGD peptides as integrin alphavbeta3 targeted radiotracers for tumor imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Radiolabelled RGD peptides and peptidomimetics for tumour targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

[18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

18F-labeled galacto and PEGylated RGD dimers for PET imaging of αvβ3 integrin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Application of RGD-containing peptides as imaging probes for alphavbeta3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

How molecular imaging is speeding up antiangiogenic drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Performance evaluation of the microPET R4 PET scanner for rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Accelerated image reconstruction using ordered subsets of projection data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

AMIDE: a free software tool for multimodality medical image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Statistical methods for assessing measurement error (reliability) in variables relevant to sports medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Reproducibility of 18F-FDG microPET studies in mouse tumor xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Exploiting the enhanced permeability and retention effect for tumor targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-010-1672-1

Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2.

21 January 2018

1 reference

12 December 2020

Blockade of alpha v beta3 and alpha v beta5 integrins by RGD mimetics induces anoikis and not integrin-mediated death in human endothelial cells

1 reference

12 December 2020

Integrins in cell adhesion and signaling

1 reference

12 December 2020

Reproducibility of metabolic measurements in malignant tumors using FDG PET

1 reference

12 December 2020

First experience with clinical-grade ([18F]FPP(RGD₂): an automated multi-step radiosynthesis for clinical PET studies

1 reference

12 December 2020

Reproducibility of 3'-deoxy-3'-(18)F-fluorothymidine microPET studies in tumor xenografts in mice

1 reference

12 December 2020

10.1007/S00259-010-1672-1

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018